Metraipolis › archive › dc_0cff19c98657

Antibody-based therapeutics and therapeutic development for diabetic retinopathy: targeting VEGF, Ang/Tie, and inflammatory pathways — Europe PMC PMID:41601934

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41601934
DOI
10.3389/fendo.2025.1710376
License (as archived)
solo-consultazione
Archived
2026-11-06T21:05:37.311Z
SHA-256 of the archived text
5f065197ee2505a86fc9b136e8669f08dd42814ecb1d83b250cbedd39a7dd0ad
Stable URL of this page
https://metraipolis.com/documento/dc_0cff19c98657

How to cite

Antibody-based therapeutics and therapeutic development for diabetic retinopathy: targeting VEGF, Ang/Tie, and inflammatory pathways — Europe PMC PMID:41601934 — Europe PMC (en), https://europepmc.org/article/MED/41601934 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_0cff19c98657 (Metraipolis archive dc_0cff19c98657, sha256 5f065197ee2505a86fc9b136e8669f08dd42814ecb1d83b250cbedd39a7dd0ad)
BibTeX
@misc{dc0cff19c98657,
  title = {Antibody-based therapeutics and therapeutic development for diabetic retinopathy: targeting VEGF, Ang/Tie, and inflammatory pathways — Europe PMC PMID:41601934},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41601934},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_0cff19c98657; sha256 5f065197ee2505a86fc9b136e8669f08dd42814ecb1d83b250cbedd39a7dd0ad},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41601934. Agents can read the archived copy with the MCP tool read_document.